These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 11182567

  • 1. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors.
    García-Garayoa E, Allemann-Tannahill L, Bläuenstein P, Willmann M, Carrel-Rémy N, Tourwé D, Iterbeke K, Conrath P, Schubiger PA.
    Nucl Med Biol; 2001 Jan; 28(1):75-84. PubMed ID: 11182567
    [Abstract] [Full Text] [Related]

  • 2. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
    García-Garayoa E, Maes V, Bläuenstein P, Blanc A, Hohn A, Tourwé D, Schubiger PA.
    Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
    [Abstract] [Full Text] [Related]

  • 3. Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
    García-Garayoa E, Bläuenstein P, Bruehlmeier M, Blanc A, Iterbeke K, Conrath P, Tourwé D, Schubiger PA.
    J Nucl Med; 2002 Mar; 43(3):374-83. PubMed ID: 11884498
    [Abstract] [Full Text] [Related]

  • 4. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M, Janssen PJ, Srinivasan A, Reubi JC, Waser B, Erion JL, Schmidt MA, Krenning EP, de Jong M.
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [Abstract] [Full Text] [Related]

  • 5. Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.
    Bergmann R, Scheunemann M, Heichert C, Mäding P, Wittrisch H, Kretzschmar M, Rodig H, Tourwé D, Iterbeke K, Chavatte K, Zips D, Reubi JC, Johannsen B.
    Nucl Med Biol; 2002 Jan; 29(1):61-72. PubMed ID: 11786277
    [Abstract] [Full Text] [Related]

  • 6. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL.
    J Med Chem; 2003 Jul 17; 46(15):3403-11. PubMed ID: 12852770
    [Abstract] [Full Text] [Related]

  • 7. Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding.
    Bruehlmeier M, Garayoa EG, Blanc A, Holzer B, Gergely S, Tourwé D, Schubiger PA, Bläuenstein P.
    Nucl Med Biol; 2002 Apr 17; 29(3):321-7. PubMed ID: 11929702
    [Abstract] [Full Text] [Related]

  • 8. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
    Zhang K, An R, Gao Z, Zhang Y, Aruva MR.
    Nucl Med Biol; 2006 May 17; 33(4):505-12. PubMed ID: 16720242
    [Abstract] [Full Text] [Related]

  • 9. Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties.
    Maes V, Garcia-Garayoa E, Bläuenstein P, Tourwé D.
    J Med Chem; 2006 Mar 09; 49(5):1833-6. PubMed ID: 16509599
    [Abstract] [Full Text] [Related]

  • 10. New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification.
    Emrarian I, Sadeghzadeh N, Abedi SM, Abediankenari S.
    Chem Biol Drug Des; 2018 Jan 09; 91(1):304-313. PubMed ID: 28816013
    [Abstract] [Full Text] [Related]

  • 11. Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.
    Nock BA, Nikolopoulou A, Reubi JC, Maes V, Conrath P, Tourwé D, Maina T.
    J Med Chem; 2006 Jul 27; 49(15):4767-76. PubMed ID: 16854083
    [Abstract] [Full Text] [Related]

  • 12. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F, Rosant C, Maes V, Abdelhak J, Raguin O, Burg S, Sarda L, Barbet J, Tourwé D, Pelaprat D, Gruaz-Guyon A.
    Bioconjug Chem; 2009 Aug 19; 20(8):1602-10. PubMed ID: 19610615
    [Abstract] [Full Text] [Related]

  • 13. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti PS, Li Z, Kandeel F, Shively JE.
    J Nucl Med; 2014 Jul 19; 55(7):1178-84. PubMed ID: 24854793
    [Abstract] [Full Text] [Related]

  • 14. Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues.
    Bläuenstein P, Garayoa EG, Rüegg D, Blanc A, Tourwé D, Beck-Sickinger A, Schubiger PA.
    Cancer Biother Radiopharm; 2004 Apr 19; 19(2):181-8. PubMed ID: 15186598
    [Abstract] [Full Text] [Related]

  • 15. Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides.
    Schubiger PA, Allemann-Tannahill L, Egli A, Schibli R, Alberto R, Carrel-Rémy N, Willmann M, Bläuenstein P, Tourwé D.
    Q J Nucl Med; 1999 Jun 19; 43(2):155-8. PubMed ID: 10429510
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y, Shi W, Zhou Z, Wagh NK, Fan W, Brusnahan SK, Garrison JC.
    Nucl Med Biol; 2015 Nov 19; 42(11):816-23. PubMed ID: 26302836
    [Abstract] [Full Text] [Related]

  • 17. A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.
    García-Garayoa E, Bläuenstein P, Blanc A, Maes V, Tourwé D, Schubiger PA.
    Eur J Nucl Med Mol Imaging; 2009 Jan 19; 36(1):37-47. PubMed ID: 18690434
    [Abstract] [Full Text] [Related]

  • 18. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
    Maschauer S, Greff C, Einsiedel J, Ott J, Tripal P, Hübner H, Gmeiner P, Prante O.
    Bioorg Med Chem; 2015 Jul 15; 23(14):4026-33. PubMed ID: 25691211
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities.
    Lundquist JT, Büllesbach EE, Dix TA.
    Bioorg Med Chem Lett; 2000 Mar 06; 10(5):453-5. PubMed ID: 10743946
    [Abstract] [Full Text] [Related]

  • 20. Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analogues.
    Lundquist JT, Dix TA.
    Bioorg Med Chem Lett; 1999 Sep 06; 9(17):2579-82. PubMed ID: 10498212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.